Recent Reports


2011-11-14: Biotechnology and Pharmaceuticals Report
5 leading Analysts; and top management from 4 Sector Firms examine this industry.
Order this Report
More Information

2011-10-31: Health Care IT Report
4 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-10-17: Medical Research, Diagnostic Substances & Life Science Tools Report
4 leading Analysts; and top management from 3 Sector Firms examine this industry.
Order this Report
More Information

2011-10-03: Medical Real Estate Report
3 leading Analysts; and top management from 3 Sector Firms examine industry.
Order this Report
More Information

2011-07-11: Medical Devices Report
5 leading Analysts; and top management from 12 Sector Firms examine this industry.
Order this Report
More Information

2011-06-27: Health Care IT Report
6 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

2011-06-13: Medical Research, Diagnostic Substances & Life Science Tools Report
5 leading Analysts; and top management from 3 Sector Firm examine this industry.
Order this Report
More Information

2011-04-04: Biotechnology and Pharmaceuticals Report
3 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-01-24: Medical Devices Report
3 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Analyst Interview Excerpt
OVERVIEW OF HEALTHCARE REITS – JERRY L. DOCTROW – STIFEL, NICOLAUS & COMPANY, INC.


Full article published: 09/21/2009


For Subscribers

Get this article online now!

Order just this article
TWST: Is it fair to say you've been covering the health care REIT industry probably longer than anyone else?
Mr. Doctrow: That's fair to say. I have been an analyst covering health care REITs since 1997, and then a little later, senior housing. From 1988 to 1997, I was with Legg Mason in the real estate consulting group and, among other things, I did work on senior housing. I have been on the board of a not-for-profit that developed a few hundred units of senior housing. I have been involved with my own parents going through both assisted living and skilled nursing. And my earlier career was in the public sector in housing, housing finance, that sort of stuff. So I'm definitely not a prototypical MBA stock analyst. My undergraduate degree is in social and behavioral science, and my graduate degree is a master's in public administration.

TWST: Given your depth and breadth of experience following this industry - and I use the term health care to include senior housing among the different types of facilities - how would you say this industry has evolved over time?
Mr. Doctrow: In the public sector, you are primarily talking about the health care REITs. But there also are a variety of operating companies that own a fair amount of health care real estate - the facility-based providers, private-pay senior housing, skilled nursing, hospital companies as well. I think probably the most dramatic change is health care REITs have come into their own as a sector. When I started covering it, health care REITs were a pretty odd commodity. They were, I think, something on the order of 5% or 6% of the NAREIT Index, and they were not included in most of the real estate indexes because they were considered something different. And what you have now is the health care REITs alone are about 15% of the NAREIT Index. Three of them are S&P 500 stocks, which is kind of remarkable given where they started. So it's become much more respectable, much more mainstream. I think health care real estate truthfully has always been a very significant asset class, but much less of it has been in the public markets. And as the health care REITs have grown significantly over the last 10 years or so and come into their own, I think it's been much more recognized as a significant investment class for the public markets.

 

Tickers included in this excerpt: ARE, BKO, BMR, ESC, FNM, FRE, HR, LTC, MPW, OH, SNH, VTR

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.